Literature DB >> 22211393

Carrier frequency of the recurrent mutation c.1643_1644delTG in the XPC gene and birth prevalence of the xeroderma pigmentosum in Morocco.

Yassamine Doubaj1, Fatima-Zahra Laarabi, Siham Chafai Elalaoui, Amina Barkat, Abdelaziz Sefiani.   

Abstract

Xeroderma pigmentosum (XP) is an autosomal recessive inherited disease which is genetically heterogeneous. The prevalence of this genodermatosis is estimated to be 1/1 000 000 in the USA; it is more common in Japan and probably in other populations with high levels of consanguinity. The molecular diagnosis and identification of mutation in patients requires the knowledge of the causative gene by the determination of XP complementation groups. Soufir et al. have reported that XPC is the major disease-causing gene with a recurrent mutation in the Mediterranean region. The mutation c.1643_1644delTG (p.Val548AlafsX25) represents alone 74% of all the XP probands tested and 87% in XP type C in North African patients with founder effect. We used molecular epidemiological methods in the present study to calculate the frequency of heterozygote for this mutation in Moroccan newborns and estimate the prevalence of XP in the Moroccan population. DNA extracted from umbilical cord blood samples of 250 newborns were tested for the recurrent XPC mutation c.1643_1644delTG using real-time polymerase chain reaction. Heterozygotes profiles were confirmed by direct sequencing. Among 250 newborns tested, one subject was heterozygous for the mutation c.1643_1644delTG. The carrier frequency was estimated to be 1/250 which would imply that the prevalence of XP would be approximately 1/80 504 considering the effect of consanguinity. This is the first report of the prevalence of XP in an Arab country and it shows that the prevalence of xeroderma pigmentosum is higher than that found in Europe and the USA.
© 2011 Japanese Dermatological Association.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22211393     DOI: 10.1111/j.1346-8138.2011.01453.x

Source DB:  PubMed          Journal:  J Dermatol        ISSN: 0385-2407            Impact factor:   4.005


  6 in total

1.  Familial predisposition to TP53/complex karyotype MDS and leukemia in DNA repair-deficient xeroderma pigmentosum.

Authors:  Alain Sarasin; Samuel Quentin; Nathalie Droin; Mourad Sahbatou; Véronique Saada; Nathalie Auger; Yannick Boursin; Philippe Dessen; Anna Raimbault; Vahid Asnafi; Jean-Luc Schmutz; Alain Taïeb; Carlos F M Menck; Filippo Rosselli; Laurianne Drieu La Rochelle; Caroline Robert; Flore Sicre de Fontbrune; Marie Sébert; Thierry Leblanc; Patricia Kannouche; Stéphane De Botton; Eric Solary; Jean Soulier
Journal:  Blood       Date:  2019-03-26       Impact factor: 22.113

2.  Macular and Retinal Nerve Fibre Layer Thinning in Xeroderma Pigmentosum: A Cross-sectional Study.

Authors:  Anna M Gruener; Ana M S Morley
Journal:  Neuroophthalmology       Date:  2018-05-22

3.  A novel frameshift mutation in the XPC gene in a Moroccan patient: a case report.

Authors:  Yassamine Doubaj; Wiam Smaili; Fatima-Zahra Laarabi; Abdelaziz Sefiani
Journal:  J Med Case Rep       Date:  2017-06-15

4.  Genetic investigation of XPA gene: high frequency of the c.682C>T mutation in Moroccan XP patients with moderate clinical profile.

Authors:  Zineb Kindil; Mohamed Amine Senhaji; Amina Bakhchane; Hicham Charoute; Soumia Chihab; Sellama Nadifi; Abdelhamid Barakat
Journal:  BMC Res Notes       Date:  2017-12-06

5.  Xeroderma pigmentosum at a tertiary care center in Saudi Arabia.

Authors:  Lenah Alwatban; Yousef Binamer
Journal:  Ann Saudi Med       Date:  2017 May-Jun       Impact factor: 1.526

6.  Further evidence of mutational heterogeneity of the XPC gene in Tunisian families: a spectrum of private and ethnic specific mutations.

Authors:  Mariem Ben Rekaya; Manel Jerbi; Olfa Messaoud; Ahlem Sabrine Ben Brick; Mohamed Zghal; Chiraz Mbarek; Ashraf Chadli-Debbiche; Meriem Jones; Mourad Mokni; Hamouda Boussen; Mohamed Samir Boubaker; Becima Fazaa; Houda Yacoub-Youssef; Sonia Abdelhak
Journal:  Biomed Res Int       Date:  2013-07-25       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.